Fig. 1: Overview of the pathophysiological process in Alzheimer’s disease.
From: New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
BBB, blood–brain barrier; CSF, cerebrospinal fluid.
Fig. 1: Overview of the pathophysiological process in Alzheimer’s disease. | Experimental & Molecular Medicine
